FDA Inspection 1063372 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Jul 26, 2018 in Spokane, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Spokane, WA (United States)